Behavior change

The Education of Dispensary Staff is Varied and Lacks Regulation

June 17, 2019 Adolescents, Anti-inflammatory properties, Anxiety, Arthritis, Behavior change, Cannabinoids, Cannabis, Cannabis Education, Cannabis News, CBD, Citizen Science, Depression, Dispensaries, Elderly, Future Medicine, History, Legislation, Mental Health, Mood, Neuropathy, Obesity, Pain, Pediatrics, Politics, Regulation, Science, Social Equity, Social Justice, Stigma, THC, Withdrawal, Women in Cannabis

Training and Practices of Cannabis Dispensary Staff

How much medical training does your local budtender possess? An online survey sent to medical marijuana dispensary staff reported only 55% of staffers had any formal training for their position, with 20% reporting some background in medical/scientific training. The analysis reported that many among the dispensary staff are recommending cannabis choices that are consistent with current evidence, but some are recommending strains that are either ineffective or exacerbate a patient’s condition. The findings of this study stress the importance of consistent and well-regulated training of dispensary staff.

View this review (yellow link) or download:

This paper is also stored here: http://bit.ly/2FfJNSC inside the CED Foundation Archive

To explore related information, click the keywords below:

A Call for Physicians to Embrace Medicinal Cannabis as a Virtuoso of Prudence

June 17, 2019 Addiction, Adverse Effects, Anxiety, Behavior change, Cannabinoids, Cannabis, Cannabis Education, Cognition, Future Medicine, History, Regulation, Social Justice

The Prescription of Medicinal Cannabis and the Virtue of Prudence: Without Phobia(S) Nor Philia(S)

A passionate physician shared his opinion on prescribing patients medicinal cannabis, promoting its use in accordance with the virtue of prudence. The piece implores physicians to identify the medicinal benefits of cannabis and embrace its side effects without fear. Medicinal cannabis has its place among prescriptions with “respect for leges artis” as long as the decision to recommend cannabis is the result of an ethical-clinically based decision.

View this review (yellow link) or download:

The Prescription of Medicinal Cannabis and the Virtue of Prudence-Without Phobia(a) Nor Philia(a)Download

This paper is also stored here: http://bit.ly/2Ff3mLc inside the CED Foundation Archive

To explore related information, click the keywords below:

Cognitive Function in Aging Cocaine Smokers is Marginally Lower than Controls

June 15, 2019 Abuse, Adverse Effects, Aging, Behavior change, Cocaine, Cognition, DSM-5, Elderly, Heavy Use, Memory, Occasional Use, Placebo-Controlled, Products, Science

Cognitive function in aging cocaine smokers

A recently published study looking to expose the functional status of older drug users has found that most of their cognitive abilities are equal to their peers who have never smoked cocaine, except for a marginally lower verbal comprehension. Similar studies should continue in order to determine how chronic drug users will affect or challenge public health systems in the future.

View this review (yellow link) or download:

Cognitive function in aging cocaine smokers Download

This paper is also stored here: http://bit.ly/2FbOUmZ inside the CED Foundation Archive

To explore related information, click keywords below:

High-potency cannabis and incident psychosis: correcting the causal assumption

June 15, 2019 Adverse Effects, Anxiety, Behavior change, Cannabinoids, Cannabis, Cannabis Education, Cannabis News, CB1, CB2, CBD, Cognition, DSM-5, Hypomania, Mental Health, Psychosis, Schizophrenia, THC

Scientists offer a strong counter-position to the belief that cannabis causes psychosis, pointing out the difference between correlation and causation. They argue that smoke exposure from any source (including cigarettes) could explain the reported link between cannabis and psychosis.

View this review (yellow link) or download:

High-potency cannabis and incident psychosis- correcting the causal assumption Download

This paper is also stored here: http://bit.ly/2WHtDr8 inside the CED Foundation Archive

To explore related information, click keywords below:

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

June 14, 2019 Anxiety, Behavior change, Cannabinoids, Cannabis, Cannabis Science, CB1, CB2, CBD, DSM-5, Future Medicine, Mental Health, Placebo-Controlled, Science

A 2018 study showed that, for patients with schizophrenia, adding CBD to ongoing antipsychotic treatment reduced psychotic activity, as compared to placebo add-on

View this review (yellow link) or download:

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia- A Multicenter Randomized Controlled Trial Download

This paper is also stored here: http://bit.ly/2WztI04 inside the CED Foundation Archive

To explore related information, click keywords below:

CBD reduces seizures and social deficits in a mouse model of Dravet syndrome

June 13, 2019 Animal Model, Autism, Behavior change, Cannabinoids, Cannabis, Cannabis Science, CB1, CB2, CBD, Future Medicine, Science

CBD treatment in a mouse model for Dravet Syndrome effectively reduced seizures and autism-like behaviors

View this review (yellow link) or download:

Cannabidiol attenuates seizures and social deficits in Dravet mice Download

This paper is also stored here: http://bit.ly/2WA1jXO inside the CED Foundation Archive

To explore related information, click keywords below:

Cannabinoids in Attention- Deficit/Hyperactivity Disorder: A randomized-controlled trial

June 13, 2019 ADD/ADHD, Adolescents, Behavior change, Cannabinoids, Cannabis, Cannabis Science, CB1, CB2, Future Medicine, Mental Health, Pediatrics, Placebo-Controlled, Science, Survey, THC

In a placebo-controlled study of a cannabis oral spray in patients with ADHD, there was no significant improvement in cognitive performance, but there was a significant improvement in hyperactivity and impulsivity.

View this review (yellow link) or download:

Cannabinoids in Attention- Deficit/Hyperactivity Disorder: A randomized-controlled trial Download

A slideshow of this study: Download

This paper is also stored here: http://bit.ly/31ykZiz inside the CED Foundation Archive

To explore related information, click keywords below:

The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?

June 13, 2019 Behavior change, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Cognition, Future Medicine, OCD, Science, THC

Animal models show that cannabis has anti-compulsive effects, and OCD patients say that cannabis improves their symptoms. Now scientists are asking for more research.

View this review (yellow link) or download:

The Endocannabinoid System- A New Treatment Target for Obsessive Compulsive Disorder?Download

This paper is also stored here: http://bit.ly/2WABCpO inside the CED Foundation Archive

To explore related information, click keywords:

Video: The Netherland’s History with Medical Marijuana

June 12, 2019 Behavior change, Cannabinoids, Cannabis, Cannabis Education, Cannabis News, CED In The News, Dr Caplan, Future Medicine, History, Law, Legislation, News, Politics, Regulation, Social Equity, Social Justice, THC, Video, Welfare

A video adaptation of “Key elements of legal environments for medical use of cannabis” that details The Netherland’s history with medical marijuana.

View this review (yellow link) or download:

Key elements of legal environments for medical use of cannabis in different countries Download

This paper is also stored here: http://bit.ly/2Y4yszz inside the CED Foundation Archive

To explore related information, click the keywords below:

Influence of the CB1 cannabinoid receptors & antidepressant effects

June 11, 2019 Adolescents, Anti-inflammatory properties, Behavior change, Bipolar Disorder, Cannabinoids, Cannabis, Cannabis Science, CB1, CBD, Depression, DSM-5, Future Medicine, Mood, Stigma, Stress, THC

Study finds that, for patients already taking antidepressants, activating and/or prohibiting the CB1 receptor in the brain might make those antidepressants more effective.

View this review (yellow link) or download:

Influence of the CB1 cannabinoid receptors on the activity of the monoaminergic system in the behavioral tests in mice
Download

This paper is also stored here: http://bit.ly/31ngEPb inside the CED Foundation Archive

To explore related information, click keywords: